EVOTF (Evotec SE) Treasury Stock: $-1.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EVOTF Evotec SE EVOTF
59 GF Score
Price $6.69
GF Value $14.72
! 5 Warning Signs
View Full Analysis

What is Evotec SE Treasury Stock?

Evotec SE EVOTF 59 Treasury Stock is $-1.3 Mil as of Mar. 2026. GuruFocus rates EVOTF with a GF Score™ of 59/100 and a GF Value™ of $14.72. The stock has 5 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. Evotec SE's treasury stock for the quarter that ended in Mar. 2026 was $-1.3 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Evotec SE Treasury Stock Historical Data

* Premium members only.

The historical data trend for Evotec SE's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evotec SE Treasury Stock Chart

Evotec SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.81

Evotec SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.81 -1.32
EVOTF
59GF Score
Evotec SE EVOTF
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evotec SE Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of $-1.3 Mil mean?
Evotec SE (EVOTF) has a Treasury Stock of $-1.3 Mil as of Mar. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Evotec SE and its competitors.
Is Evotec SE's Treasury Stock too high?
Evotec SE's current Treasury Stock is $-1.3 Mil. Overall, Evotec SE has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Evotec SE's Treasury Stock compare to ZTS and UTHR?
Evotec SE's Treasury Stock of $-1.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Drug Manufacturers company?
A good Treasury Stock depends on the Drug Manufacturers industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Evotec SE and its competitors. Evotec SE's current Treasury Stock is $-1.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evotec SE stock overvalued right now?
Evotec SE (EVOTF) has a current Treasury Stock of $-1.3 Mil. The stock's GF Value™ is $14.72, compared to a current price of $6.69 — trading 54.6% below its estimated fair value. The current Treasury Stock is $-1.3 Mil. Evotec SE's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Evotec SE (EVOTF), the current Treasury Stock is $-1.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Evotec SE (EVOTF) Overvalued in 2026?

Based on GuruFocus' analysis, Evotec SE stock appears to be undervalued. The current stock price of $6.69 is trading 54.6% below its estimated GF Value™ of $14.72.

Key valuation signals for EVOTF:

  • Treasury Stock: $-1.3 Mil
  • GF Value™: $14.72 vs. price of $6.69 (54.6% below fair value)
  • GF Score™: 59/100 with 5 warning signs

No single metric tells the full story. See the EVOTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Evotec SE Business Description

Address Essener Bogen 7, 22419 Hamburg, Hamburg, DEU, 22419
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
59GF Score

Get the complete analysis for EVOTF

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.69
Price
$14.72
GF Value